Tharimmune, Inc. Files 8-K: Material Agreement, Other Events
Ticker: CNTN · Form: 8-K · Filed: Dec 6, 2024 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Dec 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $0.001, $2.1010, $2.0310, $2.02 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financials, 8-k
TL;DR
THARIMMUNE FILES 8-K: MATERIAL AGREEMENT SIGNED, FINANCIALS FILED.
AI Summary
On December 5, 2024, Tharimmune, Inc. entered into a Material Definitive Agreement, the specifics of which are detailed within the filing. The company also reported other events and filed financial statements and exhibits. This filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing indicates significant corporate activity for Tharimmune, Inc., including the execution of a material agreement and the submission of financial information, which could impact investors' understanding of the company's current status and future direction.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to significant stock price movements, necessitating careful review by investors.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- December 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41210 (identifier) — Commission File Number
- 84-2642541 (identifier) — I. R. S. Employer Identification No.
- 1200 Route 22 East , Suite 2000 Bridgewater , NJ 08807 (address) — Address of principal executive offices
- (908) 955-3140 (phone_number) — Registrant's phone number
FAQ
What is the primary purpose of this 8-K filing for Tharimmune, Inc.?
The primary purpose of this 8-K filing is to report the entry into a Material Definitive Agreement, other events, and to file financial statements and exhibits, as of December 5, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on December 5, 2024.
What is Tharimmune, Inc.'s state of incorporation and IRS Employer Identification Number?
Tharimmune, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 84-2642541.
What is the address of Tharimmune, Inc.'s principal executive offices?
The address of Tharimmune, Inc.'s principal executive offices is 1200 Route 22 East, Suite 2000, Bridgewater, NJ 08807.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 831 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2024-12-06 17:25:21
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
- $0.001 — 's Common Stock at an exercise price of $0.001 per share and (iii) warrants (the "Comm
- $2.1010 — 's Common Stock, at a purchase price of $2.1010 per share of Common Stock (or common st
- $2.0310 — ate of issuance at an exercise price of $2.0310 per share and have a term of exercise e
- $2.02 m — cement are expected to be approximately $2.02 million, before deducting placement agent
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex4-1.htm (EX-4.1) — 98KB
- ex4-2.htm (EX-4.2) — 109KB
- ex10-1.htm (EX-10.1) — 225KB
- ex99-1.htm (EX-99.1) — 14KB
- 0001493152-24-049148.txt ( ) — 761KB
- thar-20241205.xsd (EX-101.SCH) — 3KB
- thar-20241205_lab.xml (EX-101.LAB) — 33KB
- thar-20241205_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 6, 2024 Tharimmune, Inc. /s/ Randy Milby Randy Milby Chief Executive Officer